Cargando…

Evidence for a fragile X messenger ribonucleoprotein 1 (FMR1) mRNA gain‐of‐function toxicity mechanism contributing to the pathogenesis of fragile X‐associated premature ovarian insufficiency

Fragile X‐associated premature ovarian insufficiency (FXPOI) is among a family of disorders caused by expansion of a CGG trinucleotide repeat sequence located in the 5′ untranslated region (UTR) of the fragile X messenger ribonucleoprotein 1 (FMR1) gene on the X chromosome. Women with FXPOI have a d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rosario, Roseanne, Stewart, Hazel L., Choudhury, Nila Roy, Michlewski, Gracjan, Charlet‐Berguerand, Nicholas, Anderson, Richard A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828574/ https://www.ncbi.nlm.nih.gov/pubmed/36250920 http://dx.doi.org/10.1096/fj.202200468RR

Ejemplares similares

Increased body weight in mice with fragile X messenger ribonucleoprotein 1 (Fmr1) gene mutation is associated with hypothalamic dysfunction
por: Ruggiero-Ruff, Rebecca E., et al.
Publicado: (2023)

Health and reproductive experiences of women with an FMR1 premutation with and without fragile X premature ovarian insufficiency
por: Wheeler, Anne C., et al.
Publicado: (2014)

Altered GnRH neuron and ovarian innervation characterize reproductive dysfunction linked to the Fragile X messenger ribonucleoprotein (Fmr1) gene mutation
por: Villa, Pedro A., et al.
Publicado: (2023)

The molecular mechanisms that underlie fragile X-associated premature ovarian insufficiency: is it RNA or protein based?
por: Rosario, Roseanne, et al.
Publicado: (2020)

Absence of the Fragile X messenger ribonucleoprotein alters response patterns to sounds in the auditory midbrain
por: Sibille, Jérémie, et al.
Publicado: (2022)

The effect of single-cell knockout of Fragile X Messenger Ribonucleoprotein on synaptic structural plasticity
por: Gredell, Marie, et al.
Publicado: (2023)

Cingulate protein arginine methyltransferases 1 regulates peripheral hypersensitivity via fragile X messenger ribonucleoprotein
por: Wu, Cheng, et al.
Publicado: (2023)

Reevaluation of FMR1 Hypermethylation Timing in Fragile X Syndrome
por: Mor-Shaked, Hagar, et al.
Publicado: (2018)

Fragile X Messenger Ribonucleoprotein 1 (FMR1), a novel inhibitor of osteoblast/osteocyte differentiation, regulates bone formation, mass, and strength in young and aged male and female mice
por: Deosthale, Padmini, et al.
Publicado: (2023)

Refining the risk for fragile X–associated primary ovarian insufficiency (FXPOI) by FMR1 CGG repeat size
por: Allen, Emily Graves, et al.
Publicado: (2021)

The multiple molecular facets of fragile X-associated tremor/ataxia syndrome
por: Sellier, Chantal, et al.
Publicado: (2014)

Spontaneous Coronary Artery Dissection in Females With the Fragile X FMR1 Premutation
por: McKenzie, Forrest J., et al.
Publicado: (2020)

Pirenperone relieves the symptoms of fragile X syndrome in Fmr1 knockout mice
por: Kim, Yujeong, et al.
Publicado: (2022)

Evaluation of FMR4, FMR5 and FMR6 Expression Levels as Non-Invasive Biomarkers for the Diagnosis of Fragile X-Associated Primary Ovarian Insufficiency (FXPOI)
por: Alvarez-Mora, Maria Isabel, et al.
Publicado: (2022)

Repeat-mediated epigenetic dysregulation of the FMR1 gene in the fragile X-related disorders
por: Usdin, Karen, et al.
Publicado: (2015)

Targeted Reactivation of FMR1 Transcription in Fragile X Syndrome Embryonic Stem Cells
por: Haenfler, Jill M., et al.
Publicado: (2018)

DNA Methylation, Mechanisms of FMR1 Inactivation and Therapeutic Perspectives for Fragile X Syndrome
por: Nobile, Veronica, et al.
Publicado: (2021)

FMRpolyG-positive inclusions in CNS and non-CNS organs of a fragile X premutation carrier with fragile X-associated tremor/ataxia syndrome
por: Buijsen, Ronald AM, et al.
Publicado: (2014)

Repeat-associated non-AUG (RAN) translation and other molecular mechanisms in Fragile X Tremor Ataxia Syndrome
por: Glineburg, M. Rebecca, et al.
Publicado: (2018)

Peripheral Fragile X messenger ribonucleoprotein is required for the timely closure of a critical period for neuronal susceptibility in the ventral cochlear nucleus
por: Yu, Xiaoyan, et al.
Publicado: (2023)

Mouse models of the fragile X premutation and fragile X-associated tremor/ataxia syndrome
por: Berman, Robert F, et al.
Publicado: (2014)

Autoimmune disease in mothers with the FMR1 premutation is associated with seizures in their children with fragile X syndrome
por: Chonchaiya, Weerasak, et al.
Publicado: (2010)

Repeat-mediated genetic and epigenetic changes at the FMR1 locus in the Fragile X-related disorders
por: Usdin, Karen, et al.
Publicado: (2014)

Transcriptional Reactivation of the FMR1 Gene. A Possible Approach to the Treatment of the Fragile X Syndrome†
por: Tabolacci, Elisabetta, et al.
Publicado: (2016)

Impaired hippocampal representation of place in the Fmr1-knockout mouse model of fragile X syndrome
por: Arbab, Tara, et al.
Publicado: (2018)

FMR1 premutation with Prader–Willi phenotype and fragile X‐associated tremor/ataxia syndrome
por: Martínez‐Cerdeño, Verónica, et al.
Publicado: (2017)

Fragile X Syndrome in a Female With Homozygous Full-Mutation Alleles of the FMR1 Gene
por: Vafaeie, Farzane, et al.
Publicado: (2021)

Altered expression of fragile X mental retardation-1 (FMR1) in the thymus in autoimmune myasthenia gravis
por: Thomas, Scott, et al.
Publicado: (2021)

Fragile X syndrome and fragile X-associated disorders
por: Rajaratnam, Akash, et al.
Publicado: (2017)

Understanding decreased fertility in women carriers of the FMR1 premutation: a possible mechanism for Fragile X-Associated Primary Ovarian Insufficiency (FXPOI)
por: Peprah, Emmanuel
Publicado: (2014)

Genome-wide analysis validates aberrant methylation in fragile X syndrome is specific to the FMR1 locus
por: Alisch, Reid S, et al.
Publicado: (2013)

Antipurinergic therapy corrects the autism-like features in the Fragile X (Fmr1 knockout) mouse model
por: Naviaux, Jane C, et al.
Publicado: (2015)

FMR1 Epigenetic Silencing Commonly Occurs in Undifferentiated Fragile X-Affected Embryonic Stem Cells
por: Avitzour, Michal, et al.
Publicado: (2014)

Inhibitors of Histone Deacetylases Are Weak Activators of the FMR1 Gene in Fragile X Syndrome Cell Lines
por: Dolskiy, Alexander A., et al.
Publicado: (2017)

A microRNA cluster in the Fragile‐X region expressed during spermatogenesis targets FMR1
por: Ramaiah, Madhuvanthi, et al.
Publicado: (2018)

Pharmacological Reactivation of the Silenced FMR1 Gene as a Targeted Therapeutic Approach for Fragile X Syndrome
por: Kumari, Daman, et al.
Publicado: (2019)

Gamma power abnormalities in a Fmr1-targeted transgenic rat model of fragile X syndrome
por: Kozono, Naoki, et al.
Publicado: (2020)

NMD abnormalities during brain development in the Fmr1-knockout mouse model of fragile X syndrome
por: Kurosaki, Tatsuaki, et al.
Publicado: (2021)

Neuropsychological changes in FMR1 premutation carriers and onset of fragile X-associated tremor/ataxia syndrome
por: Famula, Jessica, et al.
Publicado: (2022)

Defining the 3′Epigenetic Boundary of the FMR1 Promoter and Its Loss in Individuals with Fragile X Syndrome
por: Godler, David E., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fr2ce162vr1u7l44pco3g48tlg